Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

High Dose Buspar for Social Phobia - Pub Med Artic

Posted by JohnB on November 5, 1999, at 8:40:22

hi, everyone. here are two articles i copied from a pubmed search on "buspar AND 'social phobia'." the first article indicates a 67% "at least much improved" rate for patients able to tolerate a dose of 45mg/day or more. the second study reflects result of buspar augmentation of an ssri for the treatment of social phobia. for those patients who were only partial responders to an ssri, alone, 70% were considered responders (marked or moderate improvement) when given buspar in addition to an ssri. WHAT I GET FROM ALL OF THIS IS THAT A BUSPAR/SSRI COMBINATION SEEMS TO WORK. I'VE ALSO READ OF BUSPAR BEING USED TO ELIMINATE OR MINIMIZE THE COGNITIVE AND SEXUAL SIDE EFFECTS OF SSRI'S, THOUGH I HAVEN'T SEEN ANY CONTROLLED STUDIES.


p.s. the web site address for a free pubmed search is for those of you who haven't used this excellent resource

J Clin Psychopharmacol 1993 Aug;13(4):251-6

Buspirone in social phobia.

Schneier FR, Saoud JB, Campeas R, Fallon BA, Hollander E, Coplan J, Liebowitz MR
Anxiety Disorders Clinic, New York State Psychiatric Institute, NY 10032.

The novel anxiolytic agent buspirone has been shown to be effective in generalized anxiety disorder, but its utility in phobic disorders is less clear. We examined its efficacy in social phobia in a 12-week open trial. Twenty-one patients who met DSM-III-R criteria for social phobia and who did not respond to 1 week of single-blind placebo were treated with buspirone, and 17 completed a minimum of 2 weeks of treatment. Twelve of these 17 patients met criteria for the generalized subtype of social phobia. At week 12, 8 (47%) of the 17 patients were rated much to very much improved in social phobia symptoms on the Clinical Global Impression Scale. Of the 12 patients who were able to tolerate a dose of 45 mg/day or more, 9 (67%) were at least much improved. Significant improvement was noted on measures of social anxiety and avoidance of social situations. Ratings of generalized anxiety and depression, which were low at baseline, did not change significantly during treatment. The results suggest that buspirone may have modest efficacy in the treatment of social phobia, but confirmation in a placebo-controlled trial is required.

Publication Types:

Clinical trial
PMID: 8376612, UI: 93388903

J Affect Disord 1996 Jul 8;39(2):115-21

Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia.

Van Ameringen M, Mancini C, Wilson C
Department of Psychiatry, McMaster University, Hamilton, Ontario, Canada.

We evaluated the efficacy of buspirone, in the augmentation of social phobic symptom response to the selective serotonin reuptake inhibitors (SSRIs). Ten patients meeting DSM-III-R criteria for generalized social phobia were studied. Patients obtaining only a partial response to an adequate trial of an SSRI, received buspirone in addition to the SSRI for 8 weeks in an open trial. Seven patients (70%) were considered responders (moderate or marked improvement) and 3 (30%) were considered nonresponders (minimal improvement or no change). This study provides clinical evidence suggesting that buspirone augmentation may be a useful clinical strategy in social phobic patients who show a partial response to an SSRI.

PMID: 8827420, UI: 96424969




Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:JohnB thread:14622